Archimica S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Archimica S.p.A. - overview
Established
1947
Location
Lodi, LO, Italy
Primary Industry
Pharmaceuticals
About
Founded in 1947and based in Lodi, Italy, Archimica S. p. A. , formerly known as Clariant's Pharmaceuticals Fine Chemicals Business, operates as a manufacturer of regulatory starting materials, building blocks, intermediates, and active pharmaceutical ingredients for the generic pharmaceutical industry.
Current Investors
Mindful Capital Partners, Prime European Therapeuticals S.p.A.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals
Website
www.archimica.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Archimica S.p.A. - timeline of key events
Archimica S.p.A. - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 90,282,415 | 153,157,437 | 155,774,557 | 142,263,982 | 123,302,000 | 149,672,458 | 140,899,986 | 116,386,801 | 22,960,886 | - | - | - |
| % Revenue Growth (YoY) | - | 69.6% | 1.7% | (8.7%) | (13.3%) | 21.4% | (5.9%) | (17.4%) | (80.3%) | - | - | - |
| EBITDA (USD) | 20,950,208 | 29,707,296 | 12,688,176 | 20,353,185 | 5,948,000 | 14,403,797 | 4,617,506 | (11,639,373) | (34,873,915) | - | - | - |
| Operating Income (USD) | 9,371,551 | 15,231,468 | (887,273) | 6,773,509 | (7,174,000) | 1,461,797 | (10,372,494) | (3,267,393) | (18,221,599) | - | - | - |
| Operating Margin | 10.4% | 9.9% | (0.6%) | 4.8% | (5.8%) | 1.0% | (7.4%) | (2.8%) | (79.4%) | - | - | - |
| % EBITDA Margin | 23.2% | 19.4% | 8.1% | 14.3% | 4.8% | 9.6% | 3.3% | (10.0%) | (151.9%) | - | - | - |
| NET Income (USD) | 2,792,294 | 2,893,643 | (7,972,893) | (9,750,178) | (11,103,000) | (3,037,487) | 10,379,276 | 6,855,797 | (11,612,708) | - | - | - |
| % Net Margin | 3.1% | 1.9% | (5.1%) | (6.9%) | (9.0%) | (2.0%) | 7.4% | 5.9% | (50.6%) | - | - | - |
Archimica S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Archimica S.p.A. | - | ||||||||
| Buyout | Completed | Archimica S.p.A. | - |
Displaying 1 - 2 of 2
Archimica S.p.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.